The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oklahoma City plant on track for final capacity

30 Oct 2017 07:00

RNS Number : 9016U
Velocys PLC
30 October 2017
 

News release

Velocys plc

("Velocys" or "the Company")

30 October 2017

 

Oklahoma City plant on track to reach final capacity

Velocys plc (VLS.L), the renewable fuels company, is pleased to announce that production at ENVIA Energy's Oklahoma City gas-to-liquids plant has reached an operational capacity of 200 barrels per day (bpd), passing a key capacity milestone.

 

The plant will continue ramping up to its target operational capacity of 250 bpd. Finished, saleable products (premium renewable waxes, diesel and naphtha) are meeting customer product specifications and sales are being made to product offtakers.

 

In order to meet this milestone and support continued operations, Velocys has extended the loan arrangement it has made available to ENVIA by $0.7m to $13.4m. All other terms of the loan, which has a 10% coupon, remain unchanged.

 

Meeting this milestone enables the reversal, at the 2017 year end results, of the impairment of the loan facility as stated recently in the Company's interim results and once the plant is generating positive cash flows will ensure the servicing of the Velocys loan. Implicit to this achievement is that ENVIA has met the operational requirements for the long term land lease.

 

David Pummell, CEO of Velocys, said:

"We are pleased that ENVIA's Oklahoma City plant has reached the capacity milestone of 200 bpd. We have confidence that the talented on-site team will continue to deliver the plant improvements needed to achieve further increases in output. ENVIA's customers' tankers now arrive regularly on site and load product from the plant. The aim is now to optimise operations to maximise production and plant availability going forward, whilst always assuring safety and minimising the risk of impact to the environment.

 

"At ENVIA we have successfully demonstrated that our Fischer-Tropsch reactor and catalyst are performing in line with performance requirements at a commercial scale. The Velocys technology being used in Oklahoma City will be deployed in the biorefineries we and our partners are developing, significantly reducing technology risk and improving the likelihood of success at those plants."

 

- Ends -

 

For further information, please contact:

Velocys

David Pummell, CEO

 

+44 1235 838 621

 

Numis Securities (Nomad and joint broker)

Alex Ham

Stuart Skinner

Jamie Lillywhite

Tom Ballard

 

+44 20 7260 1000

Canaccord Genuity (Joint broker)

Henry Fitzgerald-O'Connor

Ben Griffiths

+44 20 7523 8000

 

 

 

Camarco (Financial communications & PR)

Billy Clegg

Georgia Edmonds

+44 20 3757 4983

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) prior to its release as part of this announcement.

 

www.velocys.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGGAWUUPMGQB
Date   Source Headline
14th Mar 20237:00 amRNSAppointment of Financial Adviser
13th Mar 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSBusiness Update
25th Jan 202311:07 amRNSVelocys and Bechtel Agreement
6th Jan 20233:06 pmRNSBlock listing Interim Review
12th Dec 20227:01 amRNS£2.5m UK Government grant for new e-fuels project
12th Dec 20227:00 amRNS£27m UK Government grant for Altalto project
27th Oct 20227:00 amRNSVelocys Reference Project Improved Decarbonisation
21st Sep 20227:00 amRNSInterim Results
8th Sep 20227:00 amRNSVelocys to participate in Barclays CEO Conference
1st Sep 20227:00 amRNSTotal Voting Rights
15th Aug 20227:00 amRNSUpdate on climate legislation
28th Jul 20227:00 amRNSAdditional Application for Block Admission
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSBlock listing Interim Review
1st Jul 20227:00 amRNSTotal Voting Rights
23rd Jun 20227:00 amRNSGrant of Share Option to Director
21st Jun 20223:01 pmRNSResults of Annual General Meeting
9th Jun 20227:00 amRNSAppointment of Chief Financial Officer
30th May 20227:00 amRNSMailing of 2021 annual report and AGM notice
23rd May 20224:31 pmRNSHolding(s) in Company
18th May 20224:35 pmRNSPrice Monitoring Extension
17th May 20227:00 amRNSFinal Results
13th May 20229:36 amRNSInvestor Presentation
29th Apr 20227:00 amRNSNotice of Results
19th Apr 20227:00 amRNSFurther business update
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:36 pmRNSPrice Monitoring Extension
4th Apr 20227:00 amRNSBusiness Update and Notice of Results
1st Apr 20223:26 pmRNSNotification of Major Holdings
1st Apr 20223:21 pmRNSNotification of Major Holdings
24th Mar 20227:00 amRNSSale and purchase option agreed for Altalto site
8th Mar 20224:40 pmRNSSecond Price Monitoring Extn
8th Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20221:08 pmRNSHolding(s) in Company
1st Mar 20221:04 pmRNSHolding(s) in Company
1st Mar 202212:25 pmRNSTotal Voting Rights
10th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
5th Jan 20224:30 pmRNSBlock listing Interim Review
23rd Dec 20217:00 amRNSHolding(s) in Company
22nd Dec 20217:00 amRNSHolding(s) in Company
20th Dec 202110:51 amRNSHolding(s) in Company
17th Dec 20218:02 amRNSExercise of Option over Altalto Project Site
17th Dec 20218:01 amRNSDirector/PDMR Dealings
15th Dec 202111:36 amRNSResults of General Meeting and Open Offer
26th Nov 20217:00 amRNSResult of Placing
25th Nov 20215:09 pmRNSProposed Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.